Array BioPharma Inc. (ARRY) - NASDAQ
  • wilkinson99 | Send Message 1 Jul

    Premarket Top % Gainers: $AUMN 23%, $AXU 10%, $AAU 9%, $NUGT 7%, $ECR 7%, $USLV 6%, $JNUG $SILJ $SBGL $GPL $FSM $ARRY $GFI $EXK $MUX $AMPE
    Reply
      • Colin Macleod | Send Message 7 Jun

        Handful of charts breaking through key support levels http://bit.ly/1Uo90rU $JD $BIIB $CTLT $ARRY $XL $ZBH
        Reply
          • Alexander Valtsev | Send Message 7 Jun

            $ARRY monthly 27.6% return may prove temporary and traders will have to give back those gains.
            Reply
              • EP Vantage | Send Message 6 Jun

                Array To Test BRAF/MEK Combo In Colorectal Cancer $ARRY http://seekingalpha.com/a/2db53
                Reply
                  • Colin Macleod | Send Message 4 Jun

                    $ARRY - Array Biopharma Inc - Independent Analysis Video http://bit.ly/1TPbCz8
                    Reply
                      • Bret Jensen | Send Message 16 May

                        Biotech Daily Digest: Array BioPharma In Spotlight; Pain In Biotech Continues; Contest To Buyout... $ARRY http://seekingalpha.com/a/2d7cy
                        Reply
                          • wilkinson99 | Send Message 2 Feb

                            Missed EPS expectations: $ADM $ARRY $CIT $NMR $PBI $R $SPB $TWIN
                            Reply
                              • freefdawatchlist | Send Message 30 Jan

                                http://tinyurl.com/jhf8j7x Earning play for Feb 1st - 5th: $ARRY, $WNC, $MPLX, $ATW, $TTWO, $NE, $GPRO, $DNKN, $CHTR, $FIT, $WETF
                                Reply
                                  • Michael Blake Kuritz | Send Message 6 Jan

                                    Annual Mkt for Melanoma is $1B and growing. ($GSK $BMY) MEK inhibitor plays: $ARRY $RXDX $EXEL $AZN $NVS $TECH
                                    Reply
                                      • xNotreDamex | Send Message 16 Dec 2015

                                        $ARRY undervalued, and they just had a successful stage 3 drug trial for cancer... buy it, lol
                                        Reply
                                          Company Description
                                          Array BioPharma Inc. is a biopharmaceutical company, which focuses on the discovery, development, and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Its proprietary drug development pipeline focuses on the treatment of cancer and inflammatory disease... More
                                          Sector: Services
                                          Industry: Research Services
                                          Country: United States